Open AccessSignificant and Durable Clinical Response to Sorafenib and Radiation Therapy for a Patient With Stage IV Hepatocellular Carcinoma and LRRK2 Mutation
Author(s) -
Linlin Yang,
Patrick Wald,
Sameek Roychowdhury,
Anne M. Noonan,
Li Zuo,
ChiaChen Chuang,
Julie W. Reeser,
Evan Wuthrick,
Carl Schmidt,
Terence M. Williams
Publication year - 2019
Publication title -
jco precision oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.405
H-Index - 22
ISSN - 2473-4284
DOI - 10.1200/po.18.00277
Subject(s) - sorafenib , hepatocellular carcinoma , medicine , oncology , stage (stratigraphy) , radiation therapy , lrrk2 , mutation , gastroenterology , disease , biology , genetics , paleontology , gene , parkinson's disease